3
Announcements
Trials
Browse
Landscape
Sponsor
Interventions
pembrolizumab
2
fludarabine
2
durvalumab
2
Pemetrexed
2
Cyclophosphamide
2
Cisplatin
2
130-nm albumin-bound paclitaxel
2
ruxolitinib
1
repotrectinib
1
pralsetinib
1
ponatinib
1
gilteritinib
1
fludarabine phosphate
1
cemiplimab
1
atezolizumab
1
Whole-Body Irradiation
1
Tacrolimus
1
Peripheral Blood Stem Cell Transplantation
1
Patient Reported Outcome Measures
1
Paclitaxel
1
Nivolumab
1
Mycophenolic Acid
1
Mesna
1
Melphalan
1
Immunotherapy
1
Idarubicin
1
Granulocyte Colony-Stimulating Factor
1
Gemcitabine
1
Docetaxel
1
Cytarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms by Histologic Type
×
Nimorazole
×
90 days
×
Clear all
No trials found.